Gen Surg Vivas · breast
Inflamed breast — lactational triage, aspiration fences, fistula ducts and granulomatous restraint
Fellowship viva on inflammatory breast surgical triage: lactational mastitis with continued feeding, aspiration-first abscess algorithm with size fences, MRSA-aware culture, periductal fistula duct excision with smoking cessation, and granulomatous-mastitis combination logic.
On this page
Study tools
Target exams
Write your answer
Saved on this device. No marking — you are the marker.
Examiner prompts with model answers
Lactational mastitis — diagnose clinically, empty, feed through. Mastitis is usually clinical with focal tenderness plus fever and malaise, emptying and technique correction are treatment, anti-staphylococcal cover follows when needed, and continued feeding is encouraged with no infant risk — the abscess prevented by early treatment and continued feeding never reaches theatre.[1]
Abscess — aspirate first with fences. Ultrasound-guided aspiration resolves 85 to 92% with shorter healing and better reported outcomes than drainage, while surgery stays preferred for collections over 5 cm, multiloculated or recurrent disease especially outside lactation — and the French line agrees with needle plus antibiotics under 5 cm (grade C) and no evidence-based first choice above it.[3][18]
Microbiology — culture every collection, cover MRSA by prevalence. Abscesses traditionally reflect sensitive staphylococci but MRSA now dominates some cohorts (74.5% of isolates, 88.7% lactational, mean 29.4 years), all vancomycin-susceptible with low clindamycin and co-trimoxazole resistance — so culture routinely, cover MRSA empirically where prevalent, aspirate first, and keep feeding after treatment.[16]
Periductal fistula — ducts plus smoke. Peripheral non-lactational abscesses resolve with drainage and antibiotics, but subareolar disease recurs and fistulises from keratin-plugged terminal ducts in smokers — requiring terminal-duct excision with nipple correction, not repeat drainage.[4]
Granulomatous disease — mimic, then combine locally. Granulomatous mastitis mimics inflammatory cancer, affects younger recently parous women (median 36 versus 52 years, 56% recent birth versus 5%), runs 11 to 105 weeks regardless of modality, and rewards steroid-based combination — triple therapy ranking best — with local steroids improving response (RR 1.35) and halving toxicity (RR 0.24).[19][12][13]
References8ShowHide
- [1]Spencer JP, et al. Management of mastitis in breastfeeding women. Am Fam Physician, 2008.PMID 18819238
- [3]Scardina L, et al. Management of lactational and non-lactational breast abscesses: an evidence-based framework to support breast surgeon decision-making. Updates Surg, 2026.PMID 42334816
- [4]Snider HC, et al. Management of Mastitis, Abscess, and Fistula. Surg Clin North Am, 2022.PMID 36335928
- [12]Yao S, et al. Therapeutic strategies for idiopathic granulomatous mastitis: an umbrella review of systematic reviews and meta-analyses. Front Med (Lausanne), 2026.PMID 42318409
- [13]Zhang Q, et al. The Effect of Local Steroid Administration on Idiopathic Granulomatous Mastitis: A Systematic Review andMeta-Analysis. J Surg Res, 2024.PMID 38071781
- [16]Asif N, et al. Methicillin-Resistant Staphylococcus aureus breast abscesses: Risk factors and outcomes from a tertiary care center of a lower-middle-income country. Pak J Med Sci, 2026.PMID 42136789
- [18]Laas E, et al. [Inflammatory and infectious breast mastitis outside of pregnancy and lactation: Guidelines]. J Gynecol Obstet Biol Reprod (Paris), 2015.PMID 26541563
- [19]Al-Khaffaf B, et al. Idiopathic granulomatous mastitis: a 25-year experience. J Am Coll Surg, 2008.PMID 18222379